- Poster presentation
- Open Access
Analysis of the outcome of liver transplantation patients in india - a prospective observational study
© Jakkinaboina et al.; 2015
- Published: 1 October 2015
- Renal Replacement Therapy
- Hospital Mortality
- Brain Death
- Portal Vein Thrombosis
- Hospital Length
Liver transplantation has become a widely accepted therapy for the management of the complications of cirrhosis and liver failure.
To analyze the patients undergoing the Liver transplant Recipients and the factors influencing the outcome of the patients at our tertiary care hospital.
The patients underwent liver transplantation recepients between May 2014 to Jan 2015 were analysed. The data was collected from patient records after ethics committee approval. The data captured were Age,sex, ICU and hospital length of stay, bilirubin, albumin, INR, creatinine, intubation days, readmission,cold ischemia, warm ischemia, portal vein thrombosis, SGOT, SGPT, Vasopressors use, APACHE II, SOFA Score, MELD Score, arterial anatomy, graft complications, hospital and 60day mortality, readmissions, hospital acquired infections are monitored.
Demographic data of the transplant receipients.
Mean n (%)
Age in years
Cause of liver transplant (Alcohol cirrhosis)
APACHE II at admission
SOFA at admission
Total bilirubin mg/dl
Outcome data of transplant patients.
ICU length of stay in days
Hospital length of stay in days
Cold ischemia time in minutes
Warm ischemia time in minutes
Blood products received (PRBC)
Max SGOT U/L / Max SGPT U/L / Lowest Platelets 10/mm
1227 / 592 / 42.3
Mortality and other outcomes of the patients.
Graft Whole / partial
26 / 8
76.5 / 23.5
Arterial anatomy abnormality
Renal Replacement therapy
Portal Vein Thrombosis
The hospital mortality rate in our study is 2.94% (one patient).
All the patients are ABO compatable, 2 patients had early graft rejection of which one patient liver functions has completely recovered and the other had not fully recovered. The hospital acquired infections are nil in these patients.
26 (76.47%) liver donors are brain death patients. 5 (14.71%) receipient patients are HCV positive. The factors increasing the the mortality are Increased ICU and hospital length of stay, reintubation, readmission and renal replacement therapy.
The statistically significant factors which increase the ICU length of stay are increased Bilurubin, decreased Albumin, increased ventilator days, increased Cold Ischemia and Warm Ischemia time, use of Vasopressors, lowest Platelets and raised INR.
The statistically significant factors which increase the Hospital length of stay are decreased Albumin, increased ventilator days, reintubation, use of Vasopressors, readmission and lower platelets. The 60 day mortality is similar to hospital mortality.
The patients undergoing the Liver transplant Recipients had good outcomes with less mortality and is comparable to the best centres in the world.
Hospital acquired infections are nil in these patients.
We need larger number to analyse the patients.
- Long-Term Survival After Liver Transplantation in 4,000 Consecutive Patients at a Single Center. Ann Surg. 2000, 232 (4): 490-500. 10.1097/00000658-200010000-00004. OctGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.